Novo Nordisk to build a facility in Clayton, NC
Novo Nordisk will invest $4.1 billion to build a second fill and finishing manufacturing facility in Clayton, North Carolina. The move will help the company grow its ability to produce current and future injectable treatments for people with obesity and other serious chronic diseases.